Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Potential new diuretic agents selected for detailed biological evaluation at Wakamoto

July 16, 1999

Recently issued patent covers Sanofi-Synthelabo's new M3 antagonists

July 16, 1999

Nephrin plays a key role in kidney filtration

July 16, 1999

Potassium channel openers in development at Abbott for various medical conditions

July 15, 1999

Potent, orally active AVP receptor antagonist increases urine output in rats

July 14, 1999

KRP-197: new bladder-selective antimuscarinic agent in clinical trials for bladder dysfunction

July 14, 1999

Two more European countries permit phase II studies of resiniferatoxin

July 8, 1999

Uroselective alpha-adrenoceptor blocker GYKI-16084 assessed in BPH and spinal cord injury models

July 7, 1999

Angiotensin II blockade as a strategy for preventing renal allograft nephropathy

July 2, 1999

Nippon Kayaku's new agents for micturition disorders

July 1, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...